Cell Biotech Co. Ltd (KQ:049960) — Market Cap & Net Worth
Market Cap & Net Worth: Cell Biotech Co. Ltd (049960)
Cell Biotech Co. Ltd (KQ:049960) has a market capitalization of $80.57 Million (₩118.89 Billion) as of September 18, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #20139 globally and #1072 in its home market, demonstrating a 0.13% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Cell Biotech Co. Ltd's stock price ₩15400.00 by its total outstanding shares 7720000 (7.72 Million). Also see 049960 current and non-current assets for a full breakdown of the balance sheet.
Cell Biotech Co. Ltd Market Cap History: 2015 to 2026
Cell Biotech Co. Ltd's market capitalization history from 2015 to 2026. Data shows change from $244.96 Million to $80.57 Million (-10.38% CAGR). Also see cash efficiency ratio of Cell Biotech Co. Ltd for how efficiently the company converts equity into cash flow.
Index Memberships
Cell Biotech Co. Ltd is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$234.31 Billion | 0.03% | #461 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$234.31 Billion | 0.03% | #461 of 1384 |
Weight: Cell Biotech Co. Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Cell Biotech Co. Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Cell Biotech Co. Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check 049960 stock price and chart for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.00x
Cell Biotech Co. Ltd's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.00x
Cell Biotech Co. Ltd's market cap is 0.00 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $244.96 Million | $49.50 Billion | $17.51 Billion | 0.00x | 0.01x |
| 2016 | $211.10 Million | $58.28 Billion | $18.50 Billion | 0.00x | 0.01x |
| 2017 | $176.02 Million | $61.06 Billion | $18.20 Billion | 0.00x | 0.01x |
| 2018 | $126.00 Million | $62.54 Billion | $19.38 Billion | 0.00x | 0.01x |
| 2019 | $87.90 Million | $45.96 Billion | $7.23 Billion | 0.00x | 0.01x |
| 2020 | $111.25 Million | $45.58 Billion | $3.19 Billion | 0.00x | 0.03x |
| 2021 | $91.44 Million | $46.87 Billion | $10.38 Billion | 0.00x | 0.01x |
| 2022 | $63.79 Million | $50.53 Billion | $8.28 Billion | 0.00x | 0.01x |
| 2023 | $58.70 Million | $53.79 Billion | $6.30 Billion | 0.00x | 0.01x |
| 2024 | $74.66 Million | $49.91 Billion | $15.13 Billion | 0.00x | 0.00x |
Competitor Companies of 049960 by Market Capitalization
Companies near Cell Biotech Co. Ltd in the global market cap rankings as of September 18, 2026. Review Cell Biotech Co. Ltd tangible net worth ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Cell Biotech Co. Ltd by market ranking:
- Peptron Inc (KQ:087010): Ranked #7164 globally with a market cap of $1.54 Billion USD ( ₩2.27 Trillion KRW).
- Bioneer Corporation (KQ:064550): Ranked #18070 globally with a market cap of $137.77 Million USD ( ₩203.30 Billion KRW).
- Macrogen Inc (KQ:038290): Ranked #20177 globally with a market cap of $79.73 Million USD ( ₩117.65 Billion KRW).
- Pluristem (TA:PSTI): Ranked #23894 globally with a market cap of $29.92 Million USD ( ILA11.16 Billion ILA).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #7164 | Peptron Inc | KQ:087010 | $1.54 Billion | ₩147900.00 |
| #18070 | Bioneer Corporation | KQ:064550 | $137.77 Million | ₩9200.00 |
| #20177 | Macrogen Inc | KQ:038290 | $79.73 Million | ₩11740.00 |
| #23894 | Pluristem | TA:PSTI | $29.92 Million | ILA345.00 |
Cell Biotech Co. Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Cell Biotech Co. Ltd's market cap moved from $244.96 Million to $ 80.57 Million, with a yearly change of -10.38%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩80.57 Million | +17.47% |
| 2025 | ₩68.59 Million | -8.13% |
| 2024 | ₩74.66 Million | +27.18% |
| 2023 | ₩58.70 Million | -7.98% |
| 2022 | ₩63.79 Million | -30.24% |
| 2021 | ₩91.44 Million | -17.81% |
| 2020 | ₩111.25 Million | +26.56% |
| 2019 | ₩87.90 Million | -30.23% |
| 2018 | ₩126.00 Million | -28.42% |
| 2017 | ₩176.02 Million | -16.62% |
| 2016 | ₩211.10 Million | -13.82% |
| 2015 | ₩244.96 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 18th, 2026 the market cap of Cell Biotech Co. Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $80.57 Million USD |
| MoneyControl | $80.57 Million USD |
| MarketWatch | $80.57 Million USD |
| marketcap.company | $80.57 Million USD |
| Reuters | $80.57 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Cell Biotech Co. Ltd
Cell Biotech Co., Ltd., a biotechnology company, develops and sells lactic acid bacteria in South Korea. It also offers probiotic products under the Nutra DUOLAC, LACTOClear, and LAB2PRO brands. The company also exports its products to approximately 40 countries, including the United States, Europe, Japan, and China. Cell Biotech Co., Ltd. was founded in 1995 and is based in Gimpo-si, South Korea.